Clinical trial
Impact of Donor and Recipient CYP3A5 Genetic Polymorphism on Tacrolimus Exposure in Patients With Hepatic Transplant
NCT01388387 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Donor and Recipient CYP3A5 Genetic Polymorphism on Tacrolimus Exposure in Patients With Hepatic Transplant
- Lead sponsor
- Rennes University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 22, 2012
- Completion date
- July 31, 2018
- Enrollment
- 154 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatic transplantation